-
Signature
-
/s/ Ariel E. Greenstein, Attorney-in-Fact for Lawrence Liren Chen
-
Issuer symbol
-
IDCC
-
Transactions as of
-
27 Jan 2026
-
Net transactions value
-
-$1,951,978
-
Form type
-
4
-
Filing time
-
28 Jan 2026, 16:10:56 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Chen Lawrence Liren |
President and CEO, Director |
200 BELLEVUE PARKWAY, SUITE 300, WILMINGTON |
/s/ Ariel E. Greenstein, Attorney-in-Fact for Lawrence Liren Chen |
28 Jan 2026 |
0001854214 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
IDCC |
Common Stock |
Sale |
$127,235 |
-392 |
-0.25% |
$324.58 |
158,643 |
27 Jan 2026 |
Direct |
F1, F2 |
| transaction |
IDCC |
Common Stock |
Sale |
$173,209 |
-532 |
-0.34% |
$325.58 |
158,111 |
27 Jan 2026 |
Direct |
F1, F3 |
| transaction |
IDCC |
Common Stock |
Sale |
$313,872 |
-960 |
-0.61% |
$326.95 |
157,151 |
27 Jan 2026 |
Direct |
F1, F4 |
| transaction |
IDCC |
Common Stock |
Sale |
$1,093,429 |
-3,332 |
-2.1% |
$328.16 |
153,819 |
27 Jan 2026 |
Direct |
F1, F5 |
| transaction |
IDCC |
Common Stock |
Sale |
$230,986 |
-702 |
-0.46% |
$329.04 |
153,117 |
27 Jan 2026 |
Direct |
F1, F6 |
| transaction |
IDCC |
Common Stock |
Sale |
$13,246 |
-40 |
-0.03% |
$331.16 |
153,077 |
27 Jan 2026 |
Direct |
F1 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: